OM1 Launches Multiple Sclerosis Registry with More than 20000 Patients Prospectively Followed with Deep Clinical Data – Markets Insider

Large scale multiple sclerosis registry launches. CONTEXT:  Announcement of The OM1 MS registry is a continually updating database of more than 20,000 patientsprospectively followed with deep clinical, laboratory and other data, such as longitudinal Continue Reading

Posted On :

Empagliflozin reduced the risk of cardiovascular events and hospitalization for heart failure compared to DPP-4 inhibitors in people with type 2 diabetes

First data from EMPRISE Real-World Evidence study in type 2 diabetes reveals risk reduction for patient on Empagliflozin compared to DPP-4 inhibitors CONTEXT:  Interim analysis of the EMPRISE real-world evidence Continue Reading

Posted On :

Target RWE Study Shows Significant Differences in Medication Use Among Older Patients with IBD Compared to Younger Patients – PRNewswire

CONTEXT:  Publication of analysis from an ongoing 5-year longitudinal observational study of more than 4,400 patients with inflammatory bowel disease (IBD) in the Journal of Clinical Gastroenterology.  This paper includes Continue Reading

Posted On :